Latest News about CYBN
Recent news which mentions CYBN
Cybin Receives Notice of Allowance from U.S. Patent Office
December 15, 2021
Tickers
CYBN
From Benzinga
Cybin Developing Safer, More Effective Psilocybin Therapies
December 14, 2021
Tickers
CYBN
From Benzinga
Cybin to Fund, Support Psychedelic Clinic at Manhattan Hospital
December 10, 2021
Tickers
CYBN
From Benzinga
Psilera's DMT-Derived Drug Sees Positive Results in Pre-Clinical Study
December 09, 2021
From Benzinga
Cybin Touts Highlights of 'Transformative' Second-Quarter Performance
December 02, 2021
Tickers
CYBN
From Benzinga
Cybin Announces FDA Approvals, Participation in Conference
December 01, 2021
Tickers
CYBN
From Benzinga
Psilocybin Trials For COVID-Related Distress Of Healthcare Professionals Could Validate New Psychotherapy Model
November 30, 2021
Tickers
CYBN
From Benzinga
Cybin Supports Psychedelic Treatment Clinic Through Grant
November 23, 2021
Tickers
CYBN
From Benzinga
NY's Lenox Hill Hospital With Cybin-Awarded Grant Will Provide Psychedelic Therapy To City's Underserved
November 23, 2021
Tickers
CYBN
From Benzinga
Cybin 'One Step Closer' to Creating Best Therapy for Mental Health
November 19, 2021
Tickers
CYBN
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
From Benzinga
Cybin Reports Q2 Financial Results And Latest News, Including FDA & DEA Research Approvals
November 15, 2021
Tickers
CYBN
From Benzinga
Can The Psychedelics Boom Go Bust? A Conversation With Cybin Chief Clinical Officer Dr. Alex Belser
November 14, 2021
Tickers
CYBN
From Benzinga
Cybin Unveils Data Suggesting Its Novel Psilocybin Analog Is the 'Superior Molecule'
November 11, 2021
Tickers
CYBN
From Benzinga
Cybin CEO Presenting at Jefferies London Healthcare Conference
November 11, 2021
Tickers
CYBN
From Benzinga
32 Stocks Moving in Tuesday's Pre-Market Session
November 09, 2021
From Benzinga
64 Biggest Movers From Yesterday
November 09, 2021
From Benzinga
Cybin Announces Positive Data Showing Effectiveness of Psilocybin To Treat Depression
November 08, 2021
Tickers
CYBN
From Benzinga
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval
November 08, 2021
From Benzinga
Cybin Gets DEA License To Work With Scheduled Psychedelic Molecules
November 04, 2021
From Benzinga
Cybin Inc. Receives Schedule I Manufacturing License from DEA
November 04, 2021
Tickers
CYBN
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.